Abstract:Abstract Background Single nucleotide polymorphisms within the gene locus encoding PTPN2, are associated with Crohn’s disease and ulcerative colitis. We have previously shown that, deletion of PTPN2 results in PTPN23 upregulation in intestinal epithelial cells (IEC) in vivo. PTPN23 is known to be involved in endosomal sorting and responsible for epidermal growth factor receptor (EGFR) internalization from the cell surface and thus negatively controls EGFR signalling in epithelial cells. Though PTPN23 is highly expressed in IEC and intestinal macrophages, nothing is known about its function in myeloid cells and its role in intestinal inflammation. Methods Experimental colitis was induced in PTPN23fl/flLysMCre+/- (KO) and PTPN23fl/flLysMCre-/- (WT) littermates by administration of 2% DSS in drinking water for 7 days (acute colitis) or for 4 cycles of 1.5% DSS for 7 days followed by 10 days recovery, each (chronic colitis). Immune cells were isolated from spleen and colon lamina propria from KO and WT mice and PTPN23 expression was detected by qPCR of RNA isolated after cell sorting with flow cytometry. Results The mRNA expression of PTPN23 in untreated WT mice was significantly higher in macrophages isolated from the lamina propria of the colon than in those isolated from spleen (p=0.0279). PTPN23fl/flLysMCre+/- (KO) mice were protected from DSS-induced acute colitis when compared to their WT littermates. This was apparent by a lack of DSS-induced weight loss (p=0.02); longer colon length (p=0.01), reduced endoscopic colitis scores (p=0.0016) and lower spleen weights (p=0.0063) in KO mice. In HE staining of colon tissue, the loss of crypts was less pronounced in KO mice. On mRNA level a lower expression of the pro-inflammatory cytokines interleukin 6 (IL-6) (p=0.0117) and tumour necrosis factor α (TNFα) (p=0.0024) was observed in KO compared to WT mice, supporting a reduced inflammatory response. In chronic colitis the same trends was observed, however the effects were less pronounced. WT mice lost more weight during the DSS cycles compared to KO mice, whereas no difference in weight development was detected between the genotypes in water control groups. Higher MEICSs scores were observed in WT compared to KO mice (p<0.0001) and loss of colonic crypts was more pronounced in HE stained colon samples in WT mice than KO mice. Conclusion PTPN23 deletion in myeloid cells results in protection from DSS-induced acute and chronic colitis. Additionally, a higher expression in intestinal macrophages compared to macrophages isolated from the spleen suggest a specific role in the intestinal immune system.

What problem does this paper attempt to address?

This paper aims to explore the macrophage - specific role of PTPN23 in acute and chronic colitis. Specifically, the researchers focus on the function of PTPN23 in intestinal inflammation, especially its role in myeloid cells such as macrophages. Background information indicates that single - nucleotide polymorphisms within the PTPN2 locus are associated with Crohn's disease and ulcerative colitis, and the deletion of PTPN2 leads to the up - regulation of PTPN23 in intestinal epithelial cells. Although it is known that PTPN23 is involved in endosomal sorting and is responsible for the internalization of the epidermal growth factor receptor (EGFR) from the cell surface, thereby negatively regulating EGFR signaling in epithelial cells, its function in myeloid cells and its role in intestinal inflammation are still unclear. To verify the role of PTPN23 in myeloid cells, the researchers constructed a PTPN23 conditional knockout mouse model (PTPN23fl/flLysMCre+/-, abbreviated as KO) and induced acute or chronic colitis in these mice, compared with the wild - type control group (PTPN23fl/flLysMCre-/-, abbreviated as WT). The study found that the mRNA expression of PTPN23 in colonic lamina propria macrophages of untreated WT mice was significantly higher than that of spleen - derived macrophages ($p = 0.0279$). In the DSS - induced acute colitis model, KO mice showed a protective effect against the disease, manifested as less weight loss ($p = 0.02$), longer colon length ($p = 0.01$), lower endoscopic colitis score ($p = 0.0016$) and lighter spleen weight ($p = 0.0063$). In addition, in the HE - stained colon tissue of KO mice, the crypt loss was not obvious. At the mRNA level, compared with WT mice, KO mice had lower expressions of the pro - inflammatory cytokines interleukin - 6 (IL - 6) ($p = 0.0117$) and tumor necrosis factor α (TNFα) ($p = 0.0024$), which supported the conclusion of a weakened inflammatory response. A similar trend was also observed in the chronic colitis model, but the effect was not as obvious as in the acute model. In conclusion, this study reveals that the deletion of PTPN23 in myeloid cells can protect mice from DSS - induced acute and chronic colitis, suggesting that PTPN23 may play a specific role in the intestinal immune system.

P061 The macrophage-specific role of PTPN23 in Acute and Chronic Colitis